Recruiting NA Urinary Incontinence

New treatment option for Urinary Incontinence

Official title The RECOVER Study - Postpartum Recovery of Pelvic Floor Structures and the Impact of Early Rehabilitation

ClinicalTrials.gov ID: NCT07430865

What this study is testing

What it's testing
The goal of this observational study with an embedded pilot clinical trial is to learn how the pelvic floor recovers after vaginal childbirth and whether early individualized pelvic floor muscle training can improve recovery in people who experience pelvic floor symptoms after vaginal delivery. The main questions it aims to answer are: How do pelvic floor muscles and surrounding tissues change and recover during the first year after vaginal childbirth?
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 18 and older, women only. Healthy volunteers may be eligible.

You may be able to join if

  • Individuals (over 18 years) who delivered a single child vaginally between 37 and 41 weeks of gestation, with a birthweight of at least 2500 grams.

You likely can't join if

  • Delivered via c-section
  • Multiparous with previous third- or fourth-degree tears
  • History of major urogynecological surgery
  • Known neurological disorder (e.g., stroke, multiple sclerosis) that could affect the assessment outcomes
  • Severe connective tissue disorders that could affect the assessment outcomes
  • New pregnancy of more than 6 weeks during the study period
See the full eligibility criteria
Who can join
  • Individuals (over 18 years) who delivered a single child vaginally between 37 and 41 weeks of gestation, with a birthweight of at least 2500 grams.
What rules you out
  • Delivered via c-section
  • Multiparous with previous third- or fourth-degree tears
  • History of major urogynecological surgery
  • Known neurological disorder (e.g., stroke, multiple sclerosis) that could affect the assessment outcomes
  • Severe connective tissue disorders that could affect the assessment outcomes
  • New pregnancy of more than 6 weeks during the study period
  • Pain with vaginal penetration, tampon use, or gynecological examinations that would prevent participation in assessments
  • Visible signs for wound complications assessed via REEDA tool (redness, oedema, ecchymosis, discharge, approximation) will exclude the participants from the first ultrasound assessment and vaginal palpation.

The study team makes the final eligibility decision.

Where it's taking place

  • Gothenburg, Sweden

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Gothenburg, Sweden. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.